US Stock MarketDetailed Quotes

INmune Bio (INMB)

Watchlist
  • 1.300
  • +0.030+2.36%
Trading Apr 8 13:46 ET
34.56MMarket Cap-0.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INmune Bio (INMB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
257.14%50K
0
0
0
257.14%50K
-90.97%14K
0
0
0
-63.16%14K
Operating revenue
257.14%50K
--0
--0
--0
257.14%50K
-90.97%14K
--0
--0
--0
-63.16%14K
Cost of revenue
Gross profit
Operating expense
-27.50%30.92M
-42.18%5.47M
-39.50%7.43M
-18.33%8.06M
-9.75%9.96M
42.66%42.65M
12.61%9.47M
43.34%12.29M
52.78%9.87M
70.73%11.03M
Selling and administrative expenses
8.19%10.26M
48.77%3.15M
14.74%2.55M
-19.88%2.25M
-0.94%2.32M
-1.45%9.48M
-11.92%2.11M
-14.19%2.22M
21.78%2.81M
0.43%2.34M
-General and administrative expense
8.19%10.26M
48.77%3.15M
14.74%2.55M
-19.88%2.25M
-0.94%2.32M
-1.45%9.48M
-11.92%2.11M
-14.19%2.22M
21.78%2.81M
0.43%2.34M
Research and development costs
-37.71%20.66M
-68.33%2.33M
-51.46%4.89M
-17.71%5.8M
-12.12%7.64M
63.60%33.17M
22.41%7.35M
68.20%10.07M
70.03%7.05M
110.33%8.69M
Operating profit
27.60%-30.87M
42.18%-5.47M
39.50%-7.43M
18.33%-8.06M
10.09%-9.91M
-43.35%-42.64M
-12.98%-9.47M
-44.07%-12.29M
-53.88%-9.87M
-71.52%-11.02M
Net non-operating interest income expense
Other net income (expense)
-2,824.05%-15.06M
-15.66%210K
397.93%961K
-13,882.35%-16.4M
2,175.00%166K
307.12%553K
958.62%249K
651.43%193K
232.22%119K
92.92%-8K
Special income (charges)
---16.51M
--0
--0
---16.51M
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--16.51M
--0
--0
--16.51M
----
--0
--0
--0
----
----
Other non- operating income (expenses)
162.21%1.45M
-15.66%210K
397.93%961K
-5.04%113K
2,175.00%166K
307.12%553K
958.62%249K
651.43%193K
232.22%119K
92.92%-8K
Income before tax
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
Income tax
Net income
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
Net income continuous Operations
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
Minority interest income
Net income attributable to the parent company
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.15%-45.93M
42.89%-5.26M
46.48%-6.47M
-150.95%-24.46M
11.66%-9.74M
-40.24%-42.08M
-9.63%-9.22M
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
Basic earnings per share
11.85%-1.86
55.00%-0.18
60.00%-0.24
-110.00%-1.05
29.51%-0.43
-26.35%-2.11
14.89%-0.4
-25.00%-0.6
-38.89%-0.5
-69.44%-0.61
Diluted earnings per share
11.85%-1.86
55.00%-0.18
60.00%-0.24
-110.00%-1.05
29.51%-0.43
-26.35%-2.11
14.89%-0.4
-25.00%-0.6
-38.89%-0.5
-69.44%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 257.14%50K000257.14%50K-90.97%14K000-63.16%14K
Operating revenue 257.14%50K--0--0--0257.14%50K-90.97%14K--0--0--0-63.16%14K
Cost of revenue
Gross profit
Operating expense -27.50%30.92M-42.18%5.47M-39.50%7.43M-18.33%8.06M-9.75%9.96M42.66%42.65M12.61%9.47M43.34%12.29M52.78%9.87M70.73%11.03M
Selling and administrative expenses 8.19%10.26M48.77%3.15M14.74%2.55M-19.88%2.25M-0.94%2.32M-1.45%9.48M-11.92%2.11M-14.19%2.22M21.78%2.81M0.43%2.34M
-General and administrative expense 8.19%10.26M48.77%3.15M14.74%2.55M-19.88%2.25M-0.94%2.32M-1.45%9.48M-11.92%2.11M-14.19%2.22M21.78%2.81M0.43%2.34M
Research and development costs -37.71%20.66M-68.33%2.33M-51.46%4.89M-17.71%5.8M-12.12%7.64M63.60%33.17M22.41%7.35M68.20%10.07M70.03%7.05M110.33%8.69M
Operating profit 27.60%-30.87M42.18%-5.47M39.50%-7.43M18.33%-8.06M10.09%-9.91M-43.35%-42.64M-12.98%-9.47M-44.07%-12.29M-53.88%-9.87M-71.52%-11.02M
Net non-operating interest income expense
Other net income (expense) -2,824.05%-15.06M-15.66%210K397.93%961K-13,882.35%-16.4M2,175.00%166K307.12%553K958.62%249K651.43%193K232.22%119K92.92%-8K
Special income (charges) ---16.51M--0--0---16.51M------0--0--0--------
-Less:Impairment of capital assets --16.51M--0--0--16.51M------0--0--0--------
Other non- operating income (expenses) 162.21%1.45M-15.66%210K397.93%961K-5.04%113K2,175.00%166K307.12%553K958.62%249K651.43%193K232.22%119K92.92%-8K
Income before tax -9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M
Income tax
Net income -9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M
Net income continuous Operations -9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M
Minority interest income
Net income attributable to the parent company -9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.15%-45.93M42.89%-5.26M46.48%-6.47M-150.95%-24.46M11.66%-9.74M-40.24%-42.08M-9.63%-9.22M-41.22%-12.09M-49.92%-9.75M-68.68%-11.03M
Basic earnings per share 11.85%-1.8655.00%-0.1860.00%-0.24-110.00%-1.0529.51%-0.43-26.35%-2.1114.89%-0.4-25.00%-0.6-38.89%-0.5-69.44%-0.61
Diluted earnings per share 11.85%-1.8655.00%-0.1860.00%-0.24-110.00%-1.0529.51%-0.43-26.35%-2.1114.89%-0.4-25.00%-0.6-38.89%-0.5-69.44%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +15.90%
Sample Name
Sample Code
 +13.46%
Sample Name
Sample Code
 +12.96%
4
United Sts Brent Oil Fd Lp Unit
BNO
+9.20%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+8.00%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.18%
Sample Name
Sample Code
 +14.96%
Sample Name
Sample Code
 +14.04%
4
ASE Technology
ASX
+10.93%
5
Kingsoft Cloud
KC
+10.93%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -